What is the skin lymphoma T-cell?
Skin lymphoma T-cells is a disease that affects the immune system. It is considered cancer and is a type of non-hhodgkin lymphoma. Mutations occur in T-cells that usually move into the outer layers of the skin. Rashes and finally tumors can be seen on the skin, which are symptoms of migration from mutated cells. T-cell skin lymphoma can easily spread to nearby tissues, resulting in tumor formation in other body areas.
The only way to correctly diagnose this disease is to take a skin biopsy. The skin sample is then placed under the microscope to check the cell mutation. Although this disease does not have treatment and there is a risk of expanding to other areas of the body, it is not easy to proceed. Only a small proportion of people who have this condition develop tumors. T-cell skin lymphoma has four phases that may indicate how far the disease has progressed.
One skin lymphoma phase consists of a rash that is similar to eczema or psoriasis. It can also be extremely itchy andscaly. During this time, T-cells did not create any tumors. With the second and third phase lymphoma, the skin is still scaly and red, but a swollen lymph node can also be seen on the neck or weakness. The worse scenario of the skin lymphoma is the fourth phase, which means that the lymph nodes were found obvious changes in skin and cancer cells.
There are a number of T-cell skin cancer treatment. Chemotherapy consists in dealing with cancer cells medicines that enter the bloodstream. These drugs fight with offensive cancer cells. Radiation therapy can eradicate cancer cells by sending radiation beam that helps reduce or prevent tumor growth. Phototherapy uses a combination of drugs and ultraviolet light to kill cancer cells.
other therapies can be used for skin lymphoma T-cells, all of which depend on the progression of the disease. Clinical or newer technologies are also used to fight this type of cancer. Can be used separately oro together with conventional treatment. The patient's health can also be a contributing factor in choosing a treatment option.